ID   ILRL1_RAT               Reviewed;         566 AA.
AC   Q62611; Q62612;
DT   06-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   29-MAY-2024, entry version 159.
DE   RecName: Full=Interleukin-1 receptor-like 1;
DE            EC=3.2.2.6 {ECO:0000255|PROSITE-ProRule:PRU00204};
DE   AltName: Full=Fit-1;
DE   AltName: Full=Fos-responsive gene 1 protein;
DE   Flags: Precursor;
GN   Name=Il1rl1; Synonyms=Fit1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B).
RX   PubMed=8131748; DOI=10.1002/j.1460-2075.1994.tb06367.x;
RA   Bergers G., Reikersdorfer A., Braselmann S., Graninger P., Busslinger M.;
RT   "Alternative promoter usage of the Fos-responsive gene Fit-1 generates mRNA
RT   isoforms coding for either secreted or membrane-bound proteins related to
RT   the IL-1 receptor.";
RL   EMBO J. 13:1176-1188(1994).
CC   -!- FUNCTION: Receptor for interleukin-33 (IL-33) which plays crucial roles
CC       in innate and adaptive immunity, contributing to tissue homeostasis and
CC       responses to environmental stresses together with coreceptor IL1RAP.
CC       Its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, followed by
CC       phosphorylation of MAPK3/ERK1 and/or MAPK1/ERK2, MAPK14, and MAPK8.
CC       Possibly involved in helper T-cell function (By similarity). Upon
CC       tissue injury, induces UCP2-dependent mitochondrial rewiring that
CC       attenuates the generation of reactive oxygen species and preserves the
CC       integrity of Krebs cycle required for persistent production of
CC       itaconate and subsequent GATA3-dependent differentiation of
CC       inflammation-resolving alternatively activated macrophages.
CC       {ECO:0000250|UniProtKB:P14719, ECO:0000250|UniProtKB:Q01638}.
CC   -!- FUNCTION: [Isoform B]: Inhibits IL-33 signaling.
CC       {ECO:0000250|UniProtKB:P14719}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + NAD(+) = ADP-D-ribose + H(+) + nicotinamide;
CC         Xref=Rhea:RHEA:16301, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57540, ChEBI:CHEBI:57967; EC=3.2.2.6;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00204};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16302;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00204};
CC   -!- SUBUNIT: Interacts with MYD88, IRAK1, IRAK4, and TRAF6 (By similarity).
CC       Bound to its ligand IL-33, interacts with IL1RAP to form the minimal
CC       interleukin-33 signaling complex with a 1:1:1 stoichiometry. Interacts
CC       with KIT (bound to KITLG/SCF). A mast cell-specific KITLG/SCF-induced
CC       interleukin-33 signaling complex contains IL1RL1, IL1RAP, KIT and MYD88
CC       (By similarity). Interacts with TMED1 (By similarity).
CC       {ECO:0000250|UniProtKB:P14719, ECO:0000250|UniProtKB:Q01638}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform B]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=2;
CC       Name=A; Synonyms=Membrane-bound, Fit-1M;
CC         IsoId=Q62611-1; Sequence=Displayed;
CC       Name=B; Synonyms=Soluble, Fit-1S;
CC         IsoId=Q62611-2; Sequence=VSP_002670, VSP_002671;
CC   -!- TISSUE SPECIFICITY: Isoform A is detected in spleen, lung, bone marrow
CC       and lymh node. Isoform B is predominant in fibroblasts.
CC   -!- INDUCTION: By FOS.
CC   -!- DOMAIN: The TIR domain mediates NAD(+) hydrolase (NADase) activity.
CC       Self-association of TIR domains is required for NADase activity.
CC       {ECO:0000255|PROSITE-ProRule:PRU00204}.
CC   -!- PTM: Phosphorylated by GSK3B at Ser-441; leading to proteasomal
CC       degradation. {ECO:0000250|UniProtKB:P14719}.
CC   -!- PTM: Ubiquitinated at Lys-325 in a FBXL19-mediated manner; leading to
CC       proteasomal degradation. Ubiquitination by TRAF6 via 'Lys-27'-linked
CC       polyubiquitination and deubiquitination by USP38 serves as a critical
CC       regulatory mechanism for fine-tuning IL1RL1-mediated inflammatory
CC       response. {ECO:0000250|UniProtKB:P14719, ECO:0000250|UniProtKB:Q01638}.
CC   -!- SIMILARITY: Belongs to the interleukin-1 receptor family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U04317; AAA18480.1; -; mRNA.
DR   EMBL; U04319; AAA67172.1; -; mRNA.
DR   PIR; S42632; S42632.
DR   PIR; S42633; S42633.
DR   RefSeq; NP_001121161.1; NM_001127689.1. [Q62611-1]
DR   RefSeq; NP_037169.1; NM_013037.1. [Q62611-2]
DR   AlphaFoldDB; Q62611; -.
DR   SMR; Q62611; -.
DR   STRING; 10116.ENSRNOP00000020108; -.
DR   GlyCosmos; Q62611; 6 sites, No reported glycans.
DR   GlyGen; Q62611; 6 sites.
DR   PhosphoSitePlus; Q62611; -.
DR   PaxDb; 10116-ENSRNOP00000020144; -.
DR   Ensembl; ENSRNOT00055033792; ENSRNOP00055027438; ENSRNOG00055019782. [Q62611-1]
DR   Ensembl; ENSRNOT00060046322; ENSRNOP00060038489; ENSRNOG00060026733. [Q62611-1]
DR   GeneID; 25556; -.
DR   KEGG; rno:25556; -.
DR   UCSC; RGD:2894; rat. [Q62611-1]
DR   AGR; RGD:2894; -.
DR   CTD; 9173; -.
DR   RGD; 2894; Il1rl1.
DR   eggNOG; ENOG502RU6H; Eukaryota.
DR   InParanoid; Q62611; -.
DR   OrthoDB; 4322253at2759; -.
DR   PhylomeDB; Q62611; -.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-9014843; Interleukin-33 signaling.
DR   PRO; PR:Q62611; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:MGI.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0004908; F:interleukin-1 receptor activity; IEA:InterPro.
DR   GO; GO:0002113; F:interleukin-33 binding; ISO:RGD.
DR   GO; GO:0002114; F:interleukin-33 receptor activity; ISO:RGD.
DR   GO; GO:0003953; F:NAD+ nucleosidase activity; IEA:RHEA.
DR   GO; GO:0061809; F:NAD+ nucleotidase, cyclic ADP-ribose generating; IEA:UniProtKB-EC.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:1901653; P:cellular response to peptide; IEP:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISS:UniProtKB.
DR   GO; GO:0038172; P:interleukin-33-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0030225; P:macrophage differentiation; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0002826; P:negative regulation of T-helper 1 type immune response; ISO:RGD.
DR   GO; GO:0032689; P:negative regulation of type II interferon production; ISO:RGD.
DR   GO; GO:0032722; P:positive regulation of chemokine production; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0032754; P:positive regulation of interleukin-5 production; ISO:RGD.
DR   GO; GO:0043032; P:positive regulation of macrophage activation; ISO:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   CDD; cd05757; Ig2_IL1R-like; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   Gene3D; 3.40.50.10140; Toll/interleukin-1 receptor homology (TIR) domain; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR015621; IL-1_rcpt_fam.
DR   InterPro; IPR004074; IL-1_rcpt_I/II-typ.
DR   InterPro; IPR000157; TIR_dom.
DR   InterPro; IPR035897; Toll_tir_struct_dom_sf.
DR   PANTHER; PTHR11890; INTERLEUKIN-1 RECEPTOR FAMILY MEMBER; 1.
DR   PANTHER; PTHR11890:SF7; INTERLEUKIN-1 RECEPTOR-LIKE 1; 1.
DR   Pfam; PF01582; TIR; 1.
DR   PRINTS; PR01536; INTRLKN1R12F.
DR   PRINTS; PR01537; INTRLKN1R1F.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00255; TIR; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   SUPFAM; SSF52200; Toll/Interleukin receptor TIR domain; 1.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS50104; TIR; 1.
PE   2: Evidence at transcript level;
KW   Alternative promoter usage; Alternative splicing; Cell membrane;
KW   Disulfide bond; Glycoprotein; Hydrolase; Immunoglobulin domain;
KW   Isopeptide bond; Membrane; NAD; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..566
FT                   /note="Interleukin-1 receptor-like 1"
FT                   /id="PRO_0000015444"
FT   TOPO_DOM        27..331
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        332..354
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        355..566
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          27..109
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          120..207
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          217..323
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          379..539
FT                   /note="TIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   REGION          204..216
FT                   /note="Flexible linker"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        465
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00204"
FT   MOD_RES         441
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P14719"
FT   CARBOHYD        107
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        146
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        194
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        225
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        258
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        277
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        42..93
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        117..157
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        139..187
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        240..307
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        243..286
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   CROSSLNK        325
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P14719"
FT   VAR_SEQ         328..336
FT                   /note="IDHQSTYYI -> SKECLSQIA (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:8131748"
FT                   /id="VSP_002670"
FT   VAR_SEQ         337..566
FT                   /note="Missing (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:8131748"
FT                   /id="VSP_002671"
SQ   SEQUENCE   566 AA;  64406 MW;  50554A29437A0C31 CRC64;
     MIGKWRMGLW ALAILTVPMY FIVTEGRKTS WGLENEALIV RCPQRGGAIN PVEWYYSNTN
     ERIPTQKRNR IFVSRDRLKF LPAKVEDSGI YTCVIRSPES IKTGSLNVTI YKRPPNCKIP
     DYMMYSTVDG SDKNSKITCP TIALYNWTAP VQWFKNCKAL QGPRFRAHMS YLFIDKVSHV
     DEGDYTCRFT HTENGTNYIV TATRSFTVEE KGFSTFPVIT NPPHNYTVEV EIGKTANIAC
     SACFGTASQF VAVLWQINKT RIGSFGKARI QEEKGPNKSS SNGMICLTSL LRITGVTDKD
     FSLKYDCVAM NHHGVIRHPV RLRRKQPIDH QSTYYIVAGC SLLLMFINVL VIVLKVFWIE
     VALFWRDIMA PYKTQNDGKL YDAYIIYPRV FRGSAAGTGS VEYFVHYTLP DVLENKCGYK
     LCIYGRDLLP GQDAATVVES SIQNSRRQVF VLAPHMMHSK EFAYEQEIAL HSALIQNNSK
     VILIEMEPMG EASRLQLGDL QDSLQHLVKM QGTIKWREDH VADKQSLSSK FWKHVRYQMP
     VPKRPPKMAS VAAPLSGKVC LDLKHF
//
